Bank of America’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.3K Buy
127,258
+29,457
+30% +$27.5K ﹤0.01% 5540
2025
Q4
$152K Buy
97,801
+25,637
+36% +$41K ﹤0.01% 5465
2025
Q3
$114K Sell
72,164
-12,672
-15% -$22K ﹤0.01% 6544
2025
Q2
$185K Buy
84,836
+29,771
+54% +$72.1K ﹤0.01% 6216
2025
Q1
$150K Sell
55,065
-54,840
-50% -$216K ﹤0.01% 6313
2024
Q4
$457K Sell
109,905
-87,232
-44% -$330K ﹤0.01% 5612
2024
Q3
$767K Buy
197,137
+42,802
+28% +$180K ﹤0.01% 5229
2024
Q2
$605K Buy
154,335
+21,583
+16% +$92.8K ﹤0.01% 5228
2024
Q1
$556K Sell
132,752
-12,497
-9% -$58.7K ﹤0.01% 5287
2023
Q4
$683K Buy
145,249
+58,015
+67% +$226K ﹤0.01% 5278
2023
Q3
$272K Buy
87,234
+16,865
+24% +$67.8K ﹤0.01% 5717
2023
Q2
$323K Sell
70,369
-16,608
-19% -$76.3K ﹤0.01% 5540
2023
Q1
$431K Sell
86,977
-403,275
-82% -$1.99M ﹤0.01% 5472
2022
Q4
$2.68M Sell
490,252
-237,547
-33% -$1.46M ﹤0.01% 3995
2022
Q3
$4.73M Buy
727,799
+695,433
+2,149% +$3.88M ﹤0.01% 3401
2022
Q2
$153K Sell
32,366
-34,246
-51% -$169K ﹤0.01% 6268
2022
Q1
$466K Buy
66,612
+18,465
+38% +$126K ﹤0.01% 5892
2021
Q4
$491K Buy
48,147
+45,561
+1,762% +$489K ﹤0.01% 5882
2021
Q3
$31K Buy
+2,586
New +$39K ﹤0.01% 7248

Other funds holding MXCT

Bank of America's MXCT Position: Q1 2026 in Review

Bank of America increased its MaxCyte (MXCT) stake by 30% in Q1 2026, buying an estimated $27.5K and bringing the position to 127,258 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5540.

Bank of America first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.73M in Q3 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Bank of America held 127,258 shares of MaxCyte worth $89.3K as of Q1 2026.
  • Bank of America bought 29,457 MaxCyte shares in Q1 2026, an estimated $27.5K.
  • MaxCyte made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5540 holding.
  • Bank of America first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's MaxCyte position peaked at $4.73M in Q3 2022.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.